Aupetit JF - Search Results

1

[Demonstration of the fibrillatory effect of class I anti-arrhythmia agents based on the time of fibrillation onset and electrical threshold in myocardial ischemia].

Timour Q, Aupetit JF, Loufoua-Moundanga JL, Barral-Cadière L, Freysz M, Faucon G. Timour Q, et al. Among authors: aupetit jf. Therapie. 1994 Jul-Aug;49(4):349-53. Therapie. 1994. PMID: 7878603 French.

2

Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.

Aupetit JF, Timour Q, Larbre JP, Loufoua-Moundanga J, Kioueh I, Lopez M, Faucon G. Aupetit JF, et al. Cardiovasc Drugs Ther. 1993 Apr;7(2):217-23. doi: 10.1007/BF00878511. Cardiovasc Drugs Ther. 1993. PMID: 8357775

3

Delay by a calcium antagonist, amlodipine, of the onset of primary ventricular fibrillation in myocardial ischemia.

Timour Q, Bui-Xuan B, Faucon G, Aupetit JF. Timour Q, et al. Among authors: aupetit jf. Cardiovasc Drugs Ther. 1996 Sep;10(4):447-54. doi: 10.1007/BF00051109. Cardiovasc Drugs Ther. 1996. PMID: 8924058

4

Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.

Aupetit JF, Loufoua-Moundanga J, Faucon G, Timour Q. Aupetit JF, et al. Br J Pharmacol. 1997 Feb;120(3):523-9. doi: 10.1038/sj.bjp.0700926. Br J Pharmacol. 1997. PMID: 9031759 Free PMC article.

5

Cardiac beta-adrenoreceptor activation and ventricular fibrillation under normal and ischemic conditions.

Bui-Xuan B, Aupetit JF, Freysz M, Loufoua J, Faucon G, Timour Q. Bui-Xuan B, et al. Among authors: aupetit jf. Cardiovasc Res. 1996 Dec;32(6):1056-63. doi: 10.1016/s0008-6363(96)00156-3. Cardiovasc Res. 1996. PMID: 9035900

6

Possible prevention by amlodipine of ventricular fibrillation related to brief ischemia episodes.

Timour Q, Aupetit JF, Freysz M, Frassati D, Faucon G. Timour Q, et al. Among authors: aupetit jf. Can J Physiol Pharmacol. 1996 Dec;74(12):1308-14. Can J Physiol Pharmacol. 1996. PMID: 9047040

7

Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.

Bui-Xuan B, Aupetit JF, Freysz M, Loufoua-Moundanga J, Faucon G, Timour Q. Bui-Xuan B, et al. Among authors: aupetit jf. Arch Int Pharmacodyn Ther. 1996 May-Jun;331(3):246-62. Arch Int Pharmacodyn Ther. 1996. PMID: 9124997

8

Calcium antagonists and prevention of ventricular fibrillation induced by transient or persistent ischemia.

Timour Q, Bui-Xuan B, Aupetit JF, Freysz M, Evreux JC, Faucon G. Timour Q, et al. Among authors: aupetit jf. Jpn Heart J. 1997 Mar;38(2):237-51. doi: 10.1536/ihj.38.237. Jpn Heart J. 1997. PMID: 9201111

9

Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.

Bui-Xuan B, Aupetit JF, Freysz M, Faucon G, Timour Q. Bui-Xuan B, et al. Among authors: aupetit jf. Pharmacotherapy. 1997 Jul-Aug;17(4):737-45. Pharmacotherapy. 1997. PMID: 9250551

10

Calcium channel modulators and susceptibility to ischaemic ventricular fibrillation: modification of cellular calcium overload.

Timour Q, Larbre JP, Kioueh I, Aupetit JF, Loufoua-Moundanga J, Vialle A, Faucon G. Timour Q, et al. Among authors: aupetit jf. Arch Int Pharmacodyn Ther. 1992 Jan-Feb;315:30-46. Arch Int Pharmacodyn Ther. 1992. PMID: 1384452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters